Pharmafile Logo
Pharmafocus logo
Advanced Search
000000000

Gilead asks FDA to rescind its Orphan Drug status for potential coronavirus treatment following criticism

March 26, 2020
Business Services China, Gilead, Wuhan Coronavirus, china coronavirus, coronavirus

Gilead Sciences has submitted a request for the FDA to rescind its offer of Orphan Drug designation for remdesivir in …

News
novartis_outside_1

Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy

March 25, 2020
Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy

Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …

News
0000000_1200px-paracetamol_generico

British government protecting high demand medicine for use in COVID-19 patients

March 25, 2020
Research and Development COVID-19, china coronavirus, coronavirus

The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …

News
00_transportation_isolation_system_1

Results released from first clinical trial using Danoprevir to treat COVID-19

March 25, 2020
Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus

The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …

News

FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020
Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …

News
microsoftteams-image_1

Eyeforpharma Barcelona 2020 is now a free virtual event

March 25, 2020
Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …

News
30020836983_0c6d0e542e_b

Demand for hydroxychloroquine soars after Trump says it can treat coronavirus

March 25, 2020
Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19

President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …

News
partnership

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020
Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …

News

Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia

March 24, 2020
Manufacturing and Production Cancer, Roche, acute myeloid leukamia

Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …

News
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …

Feature

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020
Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …

News

China approves Takeda’s treatment for ulcerative colitis and Crohn’s disease

March 24, 2020
Manufacturing and Production Crohn's, Takeda, Takeda China

China’s National Medical Products Administration (NMPA) has approved Takeda’s Entyvio (vedolizumab) for the treatment of adult patients with ulcerative colitis …

News
shutter

COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches

March 24, 2020
Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma

As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …

News
30562517863_f4ff8e801a_b_1

UK begins lockdown as government announce tough measures to stop the spread of COVID-19

March 24, 2020
Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic

Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …

News
fda2outsideweb

FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes

March 23, 2020
Sales and Marketing FDA, diabetes, jardiance, pharma

The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …

News
27774208927_ec889a371c_b

More young coronavirus patients being hospitalised in Europe and US compared to China

March 23, 2020
Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus

Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …

News
landing-hero-images1

ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva

March 23, 2020
Sales and Marketing Cabenuva, Canada, HIV, pharma

ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …

News
lung_cancer_on_chest_x-ray

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020
Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

News
7424861282_ee152c7c60_b

US continues sanctions against Iran despite coronavirus ravaging both nations

March 23, 2020
Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus

The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …

News
california_state_flag

Los Angeles County and California State near lockdown after “safer-at-home” mandate is announced

March 20, 2020
Medical Communications Wuhan Coronavirus, china coronavirus, coronavirus

Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026